Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balloon-occluded HAIC for unresectable hepatocellular carcinoma
ChiCTR2300077718Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in hepatocellular carcinoma (HCC), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Objective response rate. Started Apr 2024; status: completed.
02
Drugs
fluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR2300077718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077718.